Literature DB >> 21739230

Post-transcriptional regulation of mu-opioid receptor: role of the RNA-binding proteins heterogeneous nuclear ribonucleoprotein H1 and F.

Kyu Young Song1, Hack Sun Choi, Ping-Yee Law, Li-Na Wei, Horace H Loh.   

Abstract

Classical opioids have been historically used for the treatment of pain and are among the most widely used drugs for both acute severe pain and long-term pain. Morphine and endogenous mu-opioid peptides exert their pharmacological actions mainly through the mu-opioid receptor (MOR). However, the expression of opioid receptor (OR) proteins is controlled by extensive transcriptional and post-transcriptional processing. Previously, the 5'-untranslated region (UTR) of the mouse MOR was found to be important for post-transcriptional regulation of the MOR gene in neuronal cells. To identify proteins binding to the 5'-UTR as potential regulators of the mouse MOR gene, affinity column chromatography using 5'-UTR-specific RNA oligonucleotides was performed using neuroblastoma NS20Y cells. Chromatography was followed by two-dimensional gel electrophoresis and MALDI-TOF mass spectrometry. We identified two heterogeneous ribonucleoproteins (hnRNPs) that bound to RNA sequences of interest: hnRNP H1 and hnRNP F. Binding of these proteins to the RNA region was M4-region sequence-specific as confirmed by Western-blot analysis and RNA supershift assay. Furthermore, a cotransfection study showed that the presence of hnRNP H1 and F resulted in repressed expression of the mouse MOR. Our data suggest that hnRNP H1 and F can function as repressors of MOR translation dependent on the M4 (-75 to -71 bp upstream of ATG) sequences. We demonstrate for the first time a role of hnRNPs as post-transcriptional repressors in MOR gene regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21739230      PMCID: PMC3675771          DOI: 10.1007/s00018-011-0761-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  51 in total

1.  Members of the heterogeneous nuclear ribonucleoprotein H family activate splicing of an HIV-1 splicing substrate by promoting formation of ATP-dependent spliceosomal complexes.

Authors:  Michael C Schaub; Suzette R Lopez; Massimo Caputi
Journal:  J Biol Chem       Date:  2007-03-02       Impact factor: 5.157

2.  Ribosomal initiation complexes probed by toeprinting and effect of trans-acting translational regulators in bacteria.

Authors:  Pierre Fechter; Clément Chevalier; Gulnara Yusupova; Marat Yusupov; Pascale Romby; Stefano Marzi
Journal:  Methods Mol Biol       Date:  2009

3.  Structure of the 30S translation initiation complex.

Authors:  Angelita Simonetti; Stefano Marzi; Alexander G Myasnikov; Attilio Fabbretti; Marat Yusupov; Claudio O Gualerzi; Bruno P Klaholz
Journal:  Nature       Date:  2008-08-31       Impact factor: 49.962

4.  The myotonic dystrophy type 2 protein ZNF9 is part of an ITAF complex that promotes cap-independent translation.

Authors:  Vincent R Gerbasi; Andrew J Link
Journal:  Mol Cell Proteomics       Date:  2007-02-26       Impact factor: 5.911

5.  Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters.

Authors:  Cheol Kyu Hwang; Kyu Young Song; Chun Sung Kim; Hack Sun Choi; Xiao-Hong Guo; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

6.  Novel function of the poly(C)-binding protein alpha CP3 as a transcriptional repressor of the mu opioid receptor gene.

Authors:  Hack Sun Choi; Chun Sung Kim; Cheol Kyu Hwang; Kyu Young Song; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  FASEB J       Date:  2007-07-11       Impact factor: 5.191

Review 7.  RNA-binding proteins and post-transcriptional gene regulation.

Authors:  Tina Glisovic; Jennifer L Bachorik; Jeongsik Yong; Gideon Dreyfuss
Journal:  FEBS Lett       Date:  2008-03-13       Impact factor: 4.124

8.  Translational repression of mouse mu opioid receptor expression via leaky scanning.

Authors:  Kyu Young Song; Cheol Kyu Hwang; Chun Sung Kim; Hack Sun Choi; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  Nucleic Acids Res       Date:  2007-02-06       Impact factor: 16.971

9.  A proteomics approach for identification of single strand DNA-binding proteins involved in transcriptional regulation of mouse mu opioid receptor gene.

Authors:  Hack Sun Choi; Kyu Young Song; Cheol Kyu Hwang; Chun Sung Kim; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  Mol Cell Proteomics       Date:  2008-05-02       Impact factor: 5.911

10.  Transcriptional regulation of mouse mu opioid receptor gene in neuronal cells by poly(ADP-ribose) polymerase-1.

Authors:  Hack Sun Choi; Cheol Kyu Hwang; Chun Sung Kim; Kyu Young Song; Ping-Yee Law; Horace H Loh; Li-Na Wei
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

View more
  10 in total

1.  Heterogeneous nuclear ribonucleoprotein (hnRNP) F is a novel component of oligodendroglial RNA transport granules contributing to regulation of myelin basic protein (MBP) synthesis.

Authors:  Robin White; Constantin Gonsior; Nina M Bauer; Eva-Maria Krämer-Albers; Heiko J Luhmann; Jacqueline Trotter
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

Review 2.  RNA-binding proteins, neural development and the addictions.

Authors:  C D Bryant; N Yazdani
Journal:  Genes Brain Behav       Date:  2016-01       Impact factor: 3.449

3.  Post-Transcriptional Regulation of the Human Mu-Opioid Receptor (MOR) by Morphine-Induced RNA Binding Proteins hnRNP K and PCBP1.

Authors:  Kyu Young Song; Hack Sun Choi; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Cell Physiol       Date:  2016-06-24       Impact factor: 6.384

4.  Hnrnph1 is a novel regulator of alcohol reward.

Authors:  Elissa K Fultz; Michal A Coelho; Dylan Lieberman; C Leonardo Jimenez-Chavez; Camron D Bryant; Karen K Szumlinski
Journal:  Drug Alcohol Depend       Date:  2021-01-10       Impact factor: 4.492

5.  By up-regulating μ- and δ-opioid receptors, neuron-restrictive silencer factor knockdown promotes neurological recovery after ischemia.

Authors:  Hui-Min Liang; Li-Jiao Geng; Xiao-Yan Shi; Chao-Gang Zhang; Shu-Yan Wang; Guang-Ming Zhang
Journal:  Oncotarget       Date:  2017-05-23

6.  Unexplored regulatory sequences of divergently paired GLA and HNRNPH2 loci pertinent to Fabry disease in human kidney and skin cells: Presence of an active bidirectional promoter.

Authors:  Mohammed A Ibrahim Al-Obaide; Ibtisam I Al-Obaidi; Tetyana L Vasylyeva
Journal:  Exp Ther Med       Date:  2020-12-17       Impact factor: 2.447

7.  The potential consequences of bidirectional promoter methylation on GLA and HNRNPH2 expression in Fabry disease phenotypes in a family of patients carrying a GLA deletion variant.

Authors:  Mohammed A Al-Obaide; Ibtisam I Al-Obaidi; Tetyana L Vasylyeva
Journal:  Biomed Rep       Date:  2022-06-24

8.  Vimentin interacts with the 5'-untranslated region of mouse mu opioid receptor (MOR) and is required for post-transcriptional regulation.

Authors:  Kyu Young Song; Hack Sun Choi; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  RNA Biol       Date:  2013-01-25       Impact factor: 4.652

9.  Hnrnph1 Is A Quantitative Trait Gene for Methamphetamine Sensitivity.

Authors:  Neema Yazdani; Clarissa C Parker; Ying Shen; Eric R Reed; Michael A Guido; Loren A Kole; Stacey L Kirkpatrick; Jackie E Lim; Greta Sokoloff; Riyan Cheng; W Evan Johnson; Abraham A Palmer; Camron D Bryant
Journal:  PLoS Genet       Date:  2015-12-10       Impact factor: 5.917

10.  RNA-binding proteins as targets for pain therapeutics.

Authors:  June Bryan de la Peña; Zachary T Campbell
Journal:  Neurobiol Pain       Date:  2018-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.